Mumbai, Maharashtra
GST No. 27AGUPM2690J1ZO
Call 08048952877 77% Response Rate
Send Enquiry
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Vial |
| Brand | Bevazza |
| Manufacturer | Lupin |
| Composition | Bevacizumab |
| Treatment | Breast Cancer |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Vial |
| Brand | Bevacirel |
| Manufacturer | Reliance |
| Composition | Bevacizumab |
| Form | Injection |
| Treatment | Kidney Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Manufacturer | Cipla |
| Brand | Syndyma |
| Dosage Form | Injection |
| Packaging Type | Vial |
| Composition | Bevacizumab |
| Treatment | Ovarian Cancer |
Syndyma 400mg Injection is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Box |
| Manufacturer | Cipla |
| Brand | Syndyma |
| Dosage Form | Injection |
| Composition | Bevacizumab |
| Treatment | Ovarian Cancer |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Box |
| Dosage Form | Injection |
| Manufacturer | Hetero Healthcare |
| Brand | Cizumab |
| Prescription/Non prescription | Prescription |
| Composition | Bevacizumab |
| Treatment | Kidney Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Manufactured By | Zydus |
| Packaging Type | Box |
| Composition | Bevacizumab |
| Brand | Bryxta |
| Treatment | Kidney Cancer |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Form | Injection |
| Packaging Type | Box |
| Manufacturer | Mylan |
| Composition | Bevacizumab |
| Brand | Abevmy |
| Treatment | Brain Tumor |
View Complete details
Product Brochure
| Dose | 300mg |
| Form | Injection |
| Packaging Type | Box |
| Manufacturer | Zydus |
| Brand | Bryxta |
| Prescription/Non prescription | Prescription |
| Composition | Bevacizumab |
| Pack Size | 12ml |
| Treatment | Cervical Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Manufacturer | Emcure |
| Brand | Bevarest |
| Packaging Size | 1 Vial |
| Composition | Bevacizumab |
| Treatment | Cervical Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Manufactured By | Intas |
| Composition | Bevacizumab |
| Brand | Bevatas |
| Treatment | Cervical Cancer |
Bevatas 400mg Injection is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Manufactured By | Emcure |
| Packaging Type | Box |
| Composition | Bevacizumab |
| Brand | Bevarest |
| Pack Size | 1 Vial |
| Treatment | Cervical Cancer |
Bevarest 100mg Injection is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.
Additional Information:
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Brand | Versavo |
| Composition | Bevacizumab |
| Pack Type | Box |
| Manufacturer | Dr.Reddy's |
| Treatment | Kidney Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Manufacturer | Hetero Healthcare |
| Brand | Cizumab |
| Compsoition | Bevacizumab |
| Treatment | Cervical Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Manufacturer | Mylan |
| Prescription/Non prescription | Prescription |
| Brand | Abevmy |
| Composition | Bevacizumab |
| Treatment | Brain Tumor |
View Complete details
Product Brochure
| Strength | 300mg/12 ml |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Prescription/Non prescription | Prescription |
| Composition | Bevacizumab |
| Form | Injection |
| Packaging Type | Vial |
| Brand | Bevatas |
| Dosage/Strength | 300mg |
| Pack Size | 12 ml |
| Treatment | Kidney Cancer |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Vial |
| Brand | Ivzumab |
| Composition | Bevacizumab |
| Manufacturer | RPG Life Sciences |
| Treatment | Treatment Of Cancer Of Colon And Rectum |
Ivzumab 100mg injection is an anticancer medicine consisting of the active ingredient Bevacizumab. This medicine is developed to prevent the growth of tumors. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube or primary peritoneal cancer. Use effective birth control during the treatment and for at least six months after the last dose. Ivzumab 100mg injection is not recommended for adolescents and children under the age of 18. Discuss with your doctor about the preservation of ovaries if you are planning for pregnancy in the near future as this medicine may cause fertility issues in women. It would be best to avoid breastfeeding your baby as this medicine may interfere with the growth and development.
Ivzumab 100mg injection is often administered as a combination with other chemotherapy agents. Constipation, appetite loss, runny nose, fever, skin problems, and weight loss are common side effects of Ivzumab 100mg injection. Before starting treatment with this medicine, let your doctor know if you have high blood pressure, high blood sugar, stomach disorders, or heart problems. This medicine should not be taken for 28 days before and after surgery as it is associated with poor wound healing and high bleeding complications. It is advised to report to your doctor if you have any dental issues that require surgery before taking this medicine. In case you develop any visual changes or confusion, report to your doctor to prevent complications.
Uses of Ivzumab 100mg InjectionTherapeutic Effects of Ivzumab 100mg Injection
Ivzumab 100mg injection is a recombinant humanized monoclonal antibody that works as a targeted therapy in the treatment of various advanced cancers. It produces its action by selectively binding to the protein called vascular endothelial growth factor A (VEGF-A), present in the lining of blood and lymph vessels in the body. It interrupts the interaction of VEGF-A with its receptors. This further inhibits the formation of blood vessels that supply oxygen and nutrients to the tumor. As a result, it slows down the rate of progression of cancer.
View Complete details
Product Brochure
| Dose/Strength | 50 mg |
| Manufacturer | Dr. Reddy's |
| Brand | Versavo 100 |
| Packaging Size | 1 Vial of 4ml |
| Composition | Bevacizumab 100mg |
| Prescription/Non prescription | Prescription |
| Form | Injection |
| Country of Origin | Made in India |
Versavo 100mg Injection is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Vial |
| Brand | Bevazza |
| Manufacturer | Lupin |
| Composition | Bevazza 100mg Bevacizumab Injection |
| Treatment | Breast Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Vial |
| Brand | Krabeva |
| Manufacturer | Biocon |
| Composition | Bevacizumab |
| Treatment | Kidney Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Manufacturer | Reliance |
| Pack Type | Box |
| Composition | Bevacizumab |
| Treatment | Treatment Of Cancer Of Colon And Rectum |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Vial |
| Brand | Advamab |
| Manufacturer | Alkem |
| Composition | Bevacizumab |
| Treatment | Treatment Of Cancer Of Colon And Rectum |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Vial |
| Brand | Cizumab |
| Composition | Bevacizumab |
| Manufacturer | Hetero |
| Treatment | Treatment Of Cancer Of Colon And Rectum |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Vial |
| Brand | Crognoc |
| Composition | Bevacizumab |
| Manufacturer | Celon Labs |
| Treatment | Treatment Of Cancer Of Colon And Rectum |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Brand | Bevaro |
| Composition | Bevacizumab |
| Manufacturer | Oncocare |
| Pack Type | Box |
| Treatment | Kidney Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Brand | Crognoc |
| Manufacturer | Celon Labs |
| Pack Type | Box |
| Composition | Bevacizumab |
| Treatment | Kidney Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Brand | Bevnexxa |
| Composition | Bevacizumab |
| Manufacturer | Celon Labs |
| Pack Type | Box |
| Treatment | Treatment Of Cancer Of Colon And Rectum |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Brand | Avastimab |
| Composition | Bevacizumab |
| Manufacturer | RPG Life Sciences |
| Treatment | Treatment Of Cancer Of Colon And Rectum |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Brand | Advamab |
| Manufacturer | Alkem |
| Composition | Bevacizumab |
| Treatment | Treat Metastatic Breast Cancer |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Box |
| Brand | Bevicra |
| Manufacturer | Glenmark |
| Composition | Bevacizumab |
| Treatment | Kidney Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Brand | Adcimab |
| Composition | Bevacizumab |
| Manufacturer | Adley |
| Treatment | Treat Metastatic Breast Cancer |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Box |
| Brand | Vegfxta |
| Composition | Bevacizumab |
| Shelf Life | 12 Months |
| Manufacturer | Fresenius Kabi |
| Treatment | Treat Metastatic Breast Cancer |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Box |
| Brand | Bevarest |
| Composition | Bevacizumab |
| Manufacturer | Emcure |
| Treatment | Treat Metastatic Breast Cancer |
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Brand | Bevicra |
| Manufacturer | Glenmark |
| Composition | Bevacizumab |
| Treatment | Treat Metastatic Breast Cancer |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Brand | Bevatas |
| Packaging Type | Box |
| Manufacturer | Intas |
| Composition | Bevacizumab |
| Treatment | Kidney Cancer |
Bevatas 100mg Injection is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Vial |
| Brand | Halsbev |
| Shelf Life | 12 Months |
| Composition | Bevacizumab |
| Manufacturer | Halsted |
| Treatment | Breast Cancer |
Halsbev 400mg Injection is a monoclonal antibody consisting of the active ingredient Bevacizumab. It is used to treat adults with advanced large intestine cancer (colon or rectum) along with chemotherapy medication. It is also used in treating metastatic breast cancer, advanced non-small cell lung cancer and kidney cancer, and also used in advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is also used to treat persistent, recurrent cervical cancer in patients. Inform your doctor if you are allergic to Halsbev 400mg Injection or any of its ingredients. It is recommended to consult your doctor if you have an abdomen inflammation, cervical cancer, risk of bleeding or wound healing, or have an unhealed wound after the surgery. Consult your doctor if you have a skin infection, hypertension, aneurysm (enlarged or weakening blood vessels), or risk of blood clots in the arteries or veins, bleeding or bleeding-related problems, or heart problems. You may be recommended to have a dental checkup before starting to take the medicine. Inform your doctor or dentist immediately if you have pain in the mouth, teeth, or jaw, swelling inside the mouth, numbness in the jaw, or loosening of a tooth while using the medication.
The safety and efficacy of the medicine have not been established in children below 18 years of age. Consult your doctor if you are planning to get pregnant or think you may be pregnant or while you are breastfeeding. Patients who are older than 65 years may have an increased risk of stroke or heart attack, reduced blood count (WBC and platelets), diarrhea, sickness, headache, fatigue, or high blood pressure while under the medication.
Uses of Halsbev 400mg InjectionTherapeutic Effects of Halsbev 400mg Injection
Halsbev 400mg Injection is a recombinant humanized monoclonal antibody that works as a targeted therapy in the treatment of various advanced cancers. It produces its action by selectively binding to the vascular endothelial growth factor A (VEGF-A) protein, which is present in the lining of blood and lymph vessels in the body. It interrupts the interaction of VEGF-A with its receptors. This further inhibits the formation of blood vessels that supply oxygen and nutrients to the tumor. As a result, it slows down the rate of progression of cancer.
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Box |
| Manufacturer | Zydus |
| Brand | Bryxta 100 |
| Brand Name | Bryxta |
| Composition | Bevacizumab |
| Prescription/Non prescription | Prescription |
| Treatment | Metastatic Breast Cancer |
Bryxta 100mg Injection is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Vial |
| Prescription/Non prescription | Prescription |
| Dosage Form | Injection |
| Brand | Zybev |
| Manufactured By | Zydus |
| Composition | Bevacizumab |
| Pack Size | 1 Vial |
| Treatment | Used To Treat Metastatic Breast Cancer |
Zybev 100mg Injection is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.
View Complete details
Product Brochure
| Strength | 400 mg/16 ml |
| Packaging Type | Box |
| Brand | Ivzumab |
| Manufacturer | RPG Life Sciences |
| Composition | Bevacizumab |
| Treatment | Treat Metastatic Breast Cancer |
Ivzumab 400mg Injection is an anticancer medicine consisting of the active ingredient Bevacizumab. This medicine is developed to prevent the growth of tumors. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube or primary peritoneal cancer. Use effective birth control during the treatment and for at least six months after the last dose. Ivzumab 400mg Injection is not recommended for adolescents and children under the age of 18. Discuss with your doctor about the preservation of ovaries if you are planning for pregnancy in the near future as this medicine may cause fertility issues in women. It would be best to avoid breastfeeding your baby as this medicine may interfere with the growth and development.
Ivzumab 400mg Injection is often administered as a combination with other chemotherapy agents. Constipation, appetite loss, runny nose, fever, skin problems, and weight loss are common side effects of Ivzumab 400mg Injection. Before starting treatment with this medicine, let your doctor know if you have high blood pressure, high blood sugar, stomach disorders, or heart problems. This medicine should not be taken for 28 days before and after surgery as it is associated with poor wound healing and high bleeding complications. It is advised to report to your doctor if you have any dental issues that require surgery before taking this medicine. In case you develop any visual changes or confusion, report to your doctor to prevent complications.
Uses of Ivzumab 400mg InjectionIvzumab 400mg Injection is indicated to treat the following conditions:
Therapeutic Effects of Ivzumab 400mg Injection
Ivzumab 400mg Injection is a recombinant humanized monoclonal antibody that works as a targeted therapy in the treatment of various advanced cancers. It produces its action by selectively binding to the protein called vascular endothelial growth factor A (VEGF-A), present in the lining of blood and lymph vessels in the body. It interrupts the interaction of VEGF-A with its receptors. This further inhibits the formation of blood vessels that supply oxygen and nutrients to the tumor. As a result, it slows down the rate of progression of cancerView Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Vial |
| Brand | Krabeva |
| Manufacturer | Biocon |
| Composition | Bevacizumab |
| Treatment | Breast Cancer |
View Complete details
Product Brochure
| Strength | 100 mg/4 ml |
| Packaging Type | Vial |
| Brand | Bevaro |
| Manufacturer | Oncocare |
| Composition | Bevacziumab |
| Treatment | Glioblastoma |
View Complete details